A widely used COVID-19 treatment drug could be linked to mutations that create new variants of the disease, according to researchers in a new pre-print study. Published in Medxriv (pdf), researchers cited an analysis of more than 13 million viral genomes in worldwide databases and found that the drug Lagevrio, also known as molnupiravir, that there were mutations […]
Dozens of lawsuits against Merck & Co. allege plaintiffs suffer severe side effects after taking the HPV vaccine. The United States Judicial Panel on Multidistrict Litigation issued an order on Aug. 4, consolidating over 30 cases so they’ll be heard by the same judge. Lawyer Robert F. Kennedy Jr. is representing some of the plaintiffs in the […]
After several months of legal back-and-forth in the courtroom, with the FDA requesting up to 75 years to release all of their vaccine safety-related documents, a federal court has just ruled against them. Instead, that judge said the FDA has only eight months to release all of their Pfizer vaccine safety data—meaning that we might […]
The FDA is authorizing a second pill to treat COVID-19. How effective is it and who can get it? One Chinese city that’s larger than the Big Apple is again under tight lockdown, after reporting over a hundred CCP (Chinese Communist Party) virus cases. How strict are the measures and how are people reacting to it? A senator details […]
The Food and Drug Administration (FDA) on Thursday morning issued an emergency use authorization for Merck’s antiviral pill for COVID-19, more than 12 hours after giving the green light for a similar, oral drug made by Pfizer. Merck’s drug, named molnupiravir, was developed with Ridgeback Biotherapeutics, and it was shown to reduce hospitalizations and deaths from […]
Denmark on Thursday approved an antiviral COVID-19 drug produced by Merck and Ridgeback Biotherapeutics for at-risk patients with symptoms, including the elderly. The Scandinavian country became the first in the European Union to approve the antiviral treatment called molnupiravir. The pill is still under review by the European Medicines Agency (EMA). “We are recommending the pill […]
Outside advisers to the U.S. Food and Drug Administration (FDA) on Tuesday narrowly voted to recommend the agency grant emergency use authorization (EUA) for a drug from Merck and Ridgeback Biotherapeutics to treat COVID-19, called molnupiravir. Members of the FDA’s Antimicrobial Drugs Advisory Committee voted 13 for and 10 against the EUA for molnupiravir, agreeing with […]
A new analysis of clinical trial results shows that Merck’s antiviral pill for treating COVID-19 is significantly less effective than previously reported in October, the company announced on Friday. In the updated report, the drugmaker said its antiviral treatment drug, which is called molnupiravir, showed a 30 percent reduction in hospitalizations and deaths from the […]
Britain’s medicines regulator has given a green light on Thursday to an antiviral COVID-19 pill jointly developed by U.S.-based Merck and partner Ridgeback Biotherapeutics. The drug, known as molnupiravir, has been recommended by Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) to be used during the early stages of infection, within five days of the onset of symptoms, […]
